Your browser doesn't support javascript.
loading
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment.
Stark, Tibor; Di Martino, Serena; Drago, Filippo; Wotjak, Carsten T; Micale, Vincenzo.
Affiliation
  • Stark T; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Stress Neurobiology & Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
  • Di Martino S; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
  • Drago F; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
  • Wotjak CT; Department of Stress Neurobiology & Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany; Central Nervous System Diseases Research (CNSDR), Boehringer Ingelheim Pharma GmbH & Co KG, 88397 Biberach an der Riss, Germany.
  • Micale V; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy. Electronic address: vincenzomicale@inwind.it.
Pharmacol Res ; 174: 105938, 2021 12.
Article in En | MEDLINE | ID: mdl-34655773
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Psychoses, Substance-Induced / Schizophrenia / Cannabinoids / Phytochemicals Language: En Journal: Pharmacol Res Year: 2021 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Psychoses, Substance-Induced / Schizophrenia / Cannabinoids / Phytochemicals Language: En Journal: Pharmacol Res Year: 2021 Type: Article Affiliation country: Germany